Nexium Articles
AstraZeneca gains rights to sell Ironwood's IBS drug in China
24 October 2012
AstraZeneca’s blood thinner Brilinta/Brilique demonstrates cost effectiveness; new Nexium indication filed in Japan
24 October 2011
Ranbaxy debuts first approved generic of Nexium in the UK
5 September 2011
AstraZeneca looses out on European Nexium-related patent decision; downgraded by BarCap
13 June 2011
AstraZeneca earns $100 million selling Nexium co-promotion rights in Japan to Daiichi Sankyo
1 November 2010
US FDA warns of fracture risks with proton pump inhibitors; calls for class labeling change
26 May 2010
AstraZeneca opts to buy out rights to certain products from US Merck & Co JV for $647 million
2 March 2010
AstraZeneca’s CEO defends company’s stance in Bloomberg interview
15 February 2010
AstraZeneca sees strong earnings and revenue growth in2009 but a slowdown in 4th qtr
28 January 2010
US FDA warns against use of PPI Prilosec with Plavix
18 November 2009
Americans with heartburn paying too much for Nexium's 'Purple Pill,' claims Consumer Reports
30 October 2009
AstraZeneca beats consensus forecasts with 3rd quarter 2009 profits up 22% raises forecasts
29 October 2009
Retail drug sales in year to March 2009
22 May 2009
Pozen to get milestone as AZ files for PN 400
15 May 2009
AstraZeneca files for aspirin/esomeprazole
5 May 2009
Retail drug sales in year to February 2009
24 April 2009
Retail drug sales in year to January 2009
3 April 2009
US drug sales growth slows to 1.3%
30 March 2009
Retail drug sales in year to December 2008
30 March 2009
AstraZeneca's net income slips 1.6% in 4th qtr as generic competition starts to bite
9 February 2009
Retail drug sales in year to November 2008
26 January 2009
AstraZeneca files Nexium sNDA for infant GERD
12 January 2009
Retail drug sales in year to October 2008
22 December 2008
Merck & Co's 2009 outlook below predictions due to forex effects and restructuring costs
15 December 2008
Retail drug sales in year to September 2008
17 November 2008
Retail drug sales in year to August 2008
20 October 2008
Retail drug sales in year to July 2008
22 September 2008
Retail drug sales in year to June 2008
18 August 2008
Retail drug sales in year to May 2008
4 August 2008
Retail drug sales in year to April 2008
28 July 2008
Retail drug sales in year to March 2008
16 June 2008
Dr Reddy's calls bluff on AZ's Nexium patent
16 June 2008
Retail drug sales in year to February 2008
19 May 2008
Stock Commentary - Europe - week to April 21, 2008
28 April 2008
Retail drug sales in year to January 2008
21 April 2008
Merck & Co sells JV products to AZ
10 March 2008
FDA OKs Nexium for GERD in one-11 year olds
3 March 2008
AstraZeneca's net profit falls 12% on restructing charges from MedImmune buy, lower Nexium sales
11 February 2008
US clinic ships 19,000 drug firm gifts to Cameroon
28 January 2008
PPI "overprescribing" costs UK's NHS L100M
14 January 2008
"No cardiac risks with AstraZeneca PPIs," FDA
17 December 2007
Arimidex gets 6-month US patent extension
10 December 2007
EPO upholds AstraZeneca's MUPS PPI patents
26 November 2007
Sidem's PPI could have edge on nocturnal GERD
26 November 2007
Drug sales up 5% in year to September 2007
26 November 2007
AstraZeneca debuts Nexium savings prog
12 November 2007
Drug sales up 5% in year to August 2007
22 October 2007
EPO rules Nexium process patent valid
15 October 2007
Drug sales up 5% in year to July 2007
24 September 2007
US Court of Appeals endorses FDA pre-emption
3 September 2007
SMC approves AstraZeneca
18 June 2007
AstraZeneca introduces security seals on Nexium packs
19 March 2007
AstraZeneca's CEO reviews Japan ops
5 March 2007
Canadian Rx drug seizures resume in USA
19 February 2007
Stock Commentary - Europe - week to Jan 1, 2007
8 January 2007
Nexium patent setback for AstraZeneca
22 December 2006
AstraZeneca's offer to Medicare Part D enrollees
20 November 2006
US FDA approves new formulation of Nexium
30 October 2006
US FDA approves AstraZeneca's Nexium for ZES
23 October 2006
Pozen gets $40M upfront payment from AstraZeneca
2 October 2006
UHG ends US coverage for Nexium
25 September 2006
Strong data for AtstraZeneca's Nexium vs Prevacid
26 July 2006
Nexium reduces aspirin's GI complications
29 May 2006
FDA OKs Nexium DR in 12-17yr-olds
8 May 2006
Retail drug sales up 5% in 2005
10 April 2006
Strong data for AstraZeneca's Nexium vs NSAIDs/COX2s
27 March 2006
AstraZeneca may pay Merck & Co $3.3B
20 March 2006
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
